Shareholders’ Equity (Tables)

6 Months Ended

Jun. 30, 2024

Shareholders’ Equity [Abstract]

Schedule of Status of Options Under the Plan

A summary of the status of options under the Plan as of June 30, 2024 and changes during the relevant period ended on that date is presented below:

	Six months ended June 30, 2024 (unaudited)
	Number of options			Weighted average exercise price		Aggregate intrinsic value		Weighted average remaining contractual life (years)
Outstanding at beginning of period		10,520,774		$	5.03	$	2,264		7.08
Granted		3,737,570		$	3.73
Exercised		(22,602	)	$	1.10
Forfeited and cancelled		(90,745	)	$	5.78
Outstanding at end of period		14,144,997		$	4.68	$	1,673		7.40
Exercisable options		8,076,167		$	4.80	$	1,621		6.21

Schedule of Status of RSUs Under the Plan

A summary of the status of RSUs under the Plan as of June 30, 2024 and changes during the relevant period ended on that date is presented below:

	Number of RSU
Outstanding at beginning of year		813,268
Granted		686,127
Vested		(230,940	)
Forfeited and cancelled		(3,890	)
Outstanding at end of period		1,264,565

Schedule of Equity-Based Compensation Expense

The total equity-based compensation expense related to all of the Company’s equity-based awards recognized for the six months ended June 30, 2023 and 2024, was comprised as follows:

	Six months ended June 30,
	2023		2024
	Unaudited
Research and development	$	2,536	$	3,330
Marketing expenses		202		345
General and administrative		1,046		1,192
Total share-based compensation expense	$	3,784	$	4,867